Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
GNS

Genus plc

GNSLSEUnited KingdomHealthcareBiotechnologyFTSE 250

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef…more

P/E31.66xP/B2.95xROIC4.7%Dividend yield1.4%
£1.49B
Market Cap
EV: £1.70B
MOM6
QUAL4
VAL5
RSK3
GNS
£1.49B
Market Cap · EV £1.70B

Genus plc

MOM6
QUAL4
VAL5
RSK3

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef…more

Latest RNS from Genus plc

Analyst consensus: Buy

As of 21 Jul 2026, 12 analysts rate Genus plc a Buy, with 75% buy ratings and a mean price target of 3,087p (range 2,260p–3,700p), +45% vs the current price.

Strong buy: 1Buy: 8Hold: 3Sell: 0Strong sell: 0

Full analyst history →

More Healthcare companies